引用本文
  • 阳显惠,柳广南,许辉,邱正蓉.血栓素A2在抗原引起气道嗜酸性粒细胞浸润中的作用[J].广西科学,1998,5(4):308-310.    [点击复制]
  • Yang Xianhui,Liu Guangnan,Xu Hui,Qiu Zhengrong.The Role of Thromboxane A2 in Antigen-induced Eosinophil Infiltration into the Airways[J].Guangxi Sciences,1998,5(4):308-310.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 362次   下载 390 本文二维码信息
码上扫一扫!
血栓素A2在抗原引起气道嗜酸性粒细胞浸润中的作用
阳显惠, 柳广南, 许辉, 邱正蓉
0
(广西医科大学第一附属医院呼吸内科, 南宁市滨湖路6号 530021)
摘要:
为观察血栓素A2(TXA2)合成酶抑制剂OKY-046及TXA2受体拮抗剂S-1452对嗜酸性粒细胞(EOS)浸润气道的影响,探讨TXA2在EOS浸润过程的作用,应用鸡卵白蛋白(OVA)致敏和反复雾化吸入刺激小鼠以复制过敏性气道炎症模型。除对照组外,各实验组小鼠于每天OVA刺激前分别给予不同剂量OKY-046或S-1452腹腔注射,计数支气管肺泡灌洗液(BALF)中EOS数量并测定BALF中TXB2和6-酮-前列腺素F(6-Keto-PGF)水平。结果,致敏小鼠给予OVA刺激后BALF中EOS数,TXB2和6-Keto-PGF水平均显著升高,当以OKY-046或S-1452处理后,BALF中的EOS明显减小,并呈剂量相关性,而且OKY-046尚能引起TXB2水平呈剂量相关性降低。表明,TXA2对于EOS浸润到呼吸道具有明显的趋化作用,其合成酶抑制剂或受体拮抗剂对于临床治疗哮喘者可能会具有重要的价值。
关键词:  血栓素  哮喘  嗜酸性粒细胞  趋化因子  动物实验
DOI:
投稿时间:1998-05-19
基金项目:
The Role of Thromboxane A2 in Antigen-induced Eosinophil Infiltration into the Airways
Yang Xianhui, Liu Guangnan, Xu Hui, Qiu Zhengrong
(Department of Respiratory, the First Affiliated Hospital of Guangxi Medical Univ., 6 Binhulu, Nanning, 530027)
Abstract:
To investigate the effects of a thromboxane(TX) A2 synthetase inhibitor OKY-046 and TXA2 receptor antagonist S-1452 on antigen-induced eosinophil infiltration into the airways,and study the role of TXA2 in this infiltration process, the BALB/c mouse model of asthma was established by immunizing and then challenging the animals with 5% ovalbumin(OVA) repeatedly.The experimental groups were treated with different doses of OKY-046 or S-1452 respectively before OVA treatment,except the normal control groups. The numbers of eosinophil in bronchoalveolar lavage fliud(BALF) from each group were counted, and the concentrations of TXB2 and 6 Keto PGF were detected.The numbers of eosinophil and the concentrations of TXB2 and 6 Keto PGF in BALF of asthma groups were increased significantly in mice pretreated with OKY-046 or S-1452,producing a dose related decrease in eosinophil numbers,and in mice retreated with OKY-046,also producing a dose related decrease in TXB2 concentrtions.It suggests that thromboxane A2 is chemotactic to which the eosinophils infiltrate into the airways.Thromboxane synthetase inhibitor and thromboxane receptor antagonist will be of great value in treatment of asthmatics.
Key words:  thromboxane  asthma  eosinophil  chemotactic factor  animal experiment

用微信扫一扫

用微信扫一扫